Abstract
Rats were trained to discriminate a dose of the α2-adrenoceptor antagonist idazoxan (10 mg/kg IP) from saline. The discriminative stimulus produced by idazoxan was dose related and generalised to yohimbine. However, generalisation did not occur with a variety of compounds from other pharmacological categories including the α1-adrenoceptor agonist cirazoline, the α2-adrenoceptor antagonist prazosin, and the α2-adrenoceptor agonist clonidine. The idazoxan stimulus was not antagonised by either prazosin or clonidine, although it was clear that idazoxan antagonised the reductions in response rate produced by clonidine. Dose-related responding on the idazoxan-associated lever was produced by the anxiolytics buspirone and ipsapirone and by their metabolite MJ 13653 (1-PP), which has previously been shown to be an α2-adrenoceptor antagonist. In general, however, high levels of generalisation occurred with these three compounds only at doses which substantially reduced response rates. These results demonstrate that idazoxan can give rise to a discriminative stimulus which is probably mediated through antagonism at α2-adrenoceptors although the failure of clonidine to block the idazoxan stimulus is difficult to explain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett JE, Witkin JM, Mansbach RS, Skolnick P, Weissman BA (1986) Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms. J Pharmacol Exp Ther 238:1009–1013
Bianchi G, Coccia S, Della Vedova F, Garattini S (1988) The α2-adrenergic antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). Eur J Pharmacol 151:365–371
Browne RG (1981) Anxiolytics antagonize yohimbine's discriminative stimulus properties. Psychopharmacology 74:245–249
Bylund DB (1988) Subtypes of α2-adrenoceptors: pharmacological and molecular biological evidence converge. TIPS 9:356–361
Charney DS, Heninger GR, Sternberg DE (1982) Assessment of α2-adrenergic autoreceptor function in humans: effects of oral yohimbinc. Life Sci 30:2033–2041
Colpaert FC (1978) Some properties of drugs as physiological signals: The FR procedure and signal detection theory. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier, Amsterdam, pp 217–242
Colpaert FC (1984) Cross generalization with LSD and yohimbine in the rat. Eur J Pharmacol 102:541–544
Colpaert FC, Janssen PAJ (1985) Discriminative stimulus properties of xylazine in rat: Discriminability and effects of putative alpha-2 adrenoceptor agonists and antagonists. J Pharmacol Exp Ther 235:521–527
Crist J, Surprenant A (1987) Evidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neurons. Br J Pharmacol 92:342–347
Crossley DI (1984) The effects of idazoxan, an α2-adrenoceptor antagonist, in depression — a preliminary investigation. Proc 9th Int Congr Pharmacol, Abstr 1724P
Dettmar PW, Lynn AG, Tulloch IF (1983) Neuropharmacological studies in rodents on the action of RX 781094, a new selective α2-adrenoceptor antagonist. Neuropharmacology 6:729–737
Dickinson SL, Gadie B, Tulloch IF (1988) α1- and α2-adrenoceptor antagonists differentially influence locomotor and stereotyped behaviour induced byd-amphetamine and apomorphine in the rat. Psychopharmacology 96:521–527
Dickinson SL, Gadie B, Tulloch IF (1989) Effect of idazoxan on passive avoidance behaviour in adult and in aged rats. Br J Pharmacol (in press)
Doxey JC, Roach AG, Smith CFC (1983) Studies on RX 781094: a selective, potent and specific antagonist of 121-8. Br J Pharmacol 78:489–505
Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotoninergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 24:701–707
Engel JA, Johannessen K, Liljequist S, Goldstein M (1986) Activation of α2-adrenoceptors enhances haloperidol-induced suppression of operant behavior. J Neural Transm 66:107–120
File SE (1987) The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology 26:877–886
Giral P, Soubrie P, Puech AJ (1987) Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems. Eur J Pharmacol 134:113–116
Goldberg MR, Robertson D (1983) Yohimbine: a pharmacological probe for study of the α2-adrenoceptor Pharmacol Rev 35:144–180
Gower AJ, Tricklebank MD (1988) 121-11 antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Eur J Pharmacol 155:129–137
Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of “fear”-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5
Holmberg G, Gershon S (1981) Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 2:93–106
Jarbe TUC (1987) Drug discrimination learning. In: Greenshaw AJ, Dourish CT (eds) Experimental psychopharmacology. Humana, Clifton, New Jersey
Langer SZ (1978) Presynaptic receptors. Nature 275:479–480
Luttinger D, Durivage ME (1986) Alpha2-adrenergic antagonists effect on amphetamine-induced behaviors. Pharmacol Biochem Behav 25:155–160
Mansbach RS, Harrod C, Hoffman SM, Nader MA, Lei Z, Witkin JM, Barrett JE (1988) Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246:114–120
Montgomery SA (1988) Alpha-2 antagonists and depressive illness. J Psychopharmacol 2
Pinder RM (1986) 121-12 antagonists as antidepressants. Drugs of the Future 10:841–857
Robson D, Antonaccio MJ, Saelens JK, Liebman J (1978) Antagonism by mianserin and classical α-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine. Eur J Pharmacol 47:431–442
Sanger DJ (1988a) The α2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats. Psychopharmacology 95:413–417
Sanger DJ (1988b) Behavioural effects of the α2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine. Psychopharmacology 96:243–249
Sanger DJ, Blackman DE (1989) Operant behavior and the effects of centrally acting drugs. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods, vol 13. Psychopharmacology, Humana, Clifton, New Jersey
Sara SJ, Dyon-Laurent C, Devauges V (1988) Idazoxan facilitates behavioral adaptation to change in context in which a spatial task is performed. Psychopharmacology 96:550
Traber J, Davies MA, Dompert WV, Glaser T, Schuurman T, Seidel PR (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12:741–744
Van Zwieten PA (1988) Antihypertensive drugs interacting with α-and β-adrenoceptors. A review of basic pharmacology. Drugs [Suppl 6] 35:6–19
Winter JC (1978) Yohimbine-induced stimulus control in the rat. Arch Int Pharmacodyn Ther 235:86–92
Winter JC (1988) Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and ipsapirone to yohimbine. Pharmacol Biochem Behav 29:193–195
Witkin JM, Mansbach RS, Barrett JE, Bolger GT, Skolnick P, Weissman B (1987) Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior in pigeons. J Pharmacol Exp Ther 243:970–977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sanger, D.J. Discriminative stimulus effects of the α2-adrenoceptor antagonist idazoxan. Psychopharmacology 99, 117–121 (1989). https://doi.org/10.1007/BF00634464
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00634464